Total small dense LDL is the combined measurement of IDL and all sdLDL subfractions (sdLDL-1 through sdLDL-7). It quantifies the total burden of the most atherogenic lipoproteins — the particles that most effectively penetrate arterial walls, resist clearance, and accumulate in plaques.
This integrated measure is particularly valuable in metabolic syndrome, where Pattern B atherogenic dyslipidaemia can exist with apparently normal standard LDL cholesterol.
FAQs
What is the value of total small dense LDL over individual subfractions?
It provides a single integrated risk number quantifying the combined burden of all atherogenic remnant and small dense particles rather than 7+ individual values.
Does TG/HDL ratio predict total small dense LDL?
Yes. A TG/HDL ratio above 2.0 strongly predicts Pattern B phenotype with elevated small dense LDL and is a useful screening surrogate.
Can lifestyle normalise total small dense LDL?
Yes. Aggressive carbohydrate restriction and insulin sensitivity improvement can dramatically reduce total small dense LDL within 8-12 weeks.
Is this included in standard lipid panels?
No. Total small dense LDL requires specialised advanced lipid subfraction analysis.
